⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19341557 | 0.78 | — | — | |
| SCHEMBL18525736 | 0.69 | — | — | |
| SCHEMBL14619476 | 0.67 | — | — | |
| SCHEMBL15390762 | 0.64 | — | — | |
| SCHEMBL10075701 | 0.63 | — | — | |
| SCHEMBL4011771 | 0.60 | — | — | |
| SCHEMBL10048371 | 0.59 | — | — | |
| SCHEMBL5539361 | 0.59 | — | — | |
| SCHEMBL10296553 | 0.57 | — | — | |
| SCHEMBL17213836 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108752241-A | Acyl group guanidine for treating arthropathy | 默克专利股份公司 | 2018-11-06 | — | — | CN | claimed |
| WO-2025053198-A1 | HALF-DRY SMELL COMPOSITION AND MASKING FRAGRANCE COMPOSITION | 高砂香料工業株式会社 | 2025-03-13 | — | — | WO | disclosed |
| US-20240217955-A1 | SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | SIGNAL PHARMACEUTICALS, LLC | 2024-07-04 | — | — | US | disclosed |
| US-20240067632-A1 | WEE1 Degrading Compounds and Uses Thereof | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-02-29 | — | — | US | disclosed |
| US-11911386-B2 | Methods of treating B-cell proliferative disorder | BEIGENE SWITZERLAND GMBH (CH) | 2024-02-27 | — | — | US | disclosed |
| US-20240025851-A1 | Modulators of BCL6 as Ligand Directed Degraders | CELGENE CORPORATION (US) | 2024-01-25 | — | — | US | disclosed |
| US-20240025891-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES | CELGENE CORPORATION | 2024-01-25 | — | — | US | disclosed |
| US-11873283-B2 | Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith | CELGENE CORPORATION (US) | 2024-01-16 | — | — | US | disclosed |
| US-20230398122-A1 | METHODS OF TREATING B-CELL PROLIFERATIVE DISORDER | BEONE MEDICINES I GMBH (CH) | 2023-12-14 | — | — | US | disclosed |
| US-11827640-B2 | Substituted pyrazolo[1,5-a]pyrimidines as CFTR modulators | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2023-11-28 | — | — | US | disclosed |
| US-20070191312-A1 | NOVEL HETEROCYCLIC COMPOUNDS, PREPARATION PROCESS AND INTERMEDIATES, AND USE AS MEDICAMENTS, IN PARTICULAR AS BETA-LACTAMASE INHIBITORS AND ANTIBACTERIALS | MUSICKI BRANISLAV | 2007-08-16 | — | — | US | disclosed |
| CN-1933844-A | Phosphonate compounds having immuno-modulatory activity | GILEAD SCIENCES INC (US) | 2007-03-21 | — | — | CN | disclosed |
| WO-2007030680-A2 | TRIAZOLE DERIVATIVES USEFUL AS AXL INHIBITORS | RIGEL PHARMACEUTICALS, INC. (US) | 2007-03-15 | — | — | WO | disclosed |
| US-20070054933-A1 | 17-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators | MERCK & CO., INC (US) | 2007-03-08 | — | — | US | disclosed |
| US-20070049495-A1 | Ethylene derivatives and pesticides containing said derivatives | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-03-01 | — | — | US | disclosed |
| CN-1889955-A | Tricyclic imidazopyridines for use as gastric secretion inhibitors | ALTANA PHARMA AG (DE) | 2007-01-03 | — | — | CN | disclosed |
| CN-1819832-A | Kinase inhibitory phosphonate analogs | GILEAD SCIENCES INC (US) | 2006-08-16 | — | — | CN | disclosed |
| CN-1780631-A | anticancer phosphonate analogs | GILEAD SCIENCES INC (US) | 2006-05-31 | — | — | CN | disclosed |
| CN-1780630-A | Phosphonate compounds having immunomodulatory activity | GILEAD SCIENCES INC (US) | 2006-05-31 | — | — | CN | disclosed |
| CN-1780643-A | Antiviral phosphonate analogs | GILEAD SCIENCES INC (US) | 2006-05-31 | — | — | CN | disclosed |